Navigation Links
People With Diabetes May Have All-Natural Citrus Supplement To Help Lower Blood Glucose and Cholesterol Levels
Date:4/9/2008

additional six-month study is underway to evaluate Diabetinol(TM) treatment in a larger sample of people with type 2 diabetes.

About KGK Synergize Inc.:

KGK Synergize provides contract research services to the health nutrition, biotechnology and pharmaceutical industries, which include analytical chemistry, in vitro assays, in vivo models, toxicology and human clinical trials.

In addition to its contract research capabilities, KGK has a Product Development Division which brings new and innovative natural health products to the point where they are ready to be manufactured and marketed. These products include Sytrinol(TM) for cardiovascular health, Diabetinol(TM) for the treatment and/or prevention of Type II Diabetes, and Dermytol(TM), a new product for the protection of sun damage to the skin.


'/>"/>
SOURCE KGK Synergize Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Resource Available for People With Lymphoma
2. 38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty
3. LAP-BAND(R) System Weight-Loss Surgery Associated With More Than 70 Percent Reduced Risk of Death in People With Severe Obesity
4. Treating Depression Prolongs Life for Older People with Diabetes
5. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
6. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
7. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
8. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
11. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ss., Nov. 30 According to Millenni...edical technology market intelligence, the nearly ...ned by almost 5% over 2008 as patients chose to de...c crisis. The market will, however, begin recovery...re-recession growth rates of over 15%. MRG,s facia...
(Date:11/30/2009)... 30 Minimally-invasive procedures ...y, particularly in oncology, cardiology and women,...mage-guided navigation expected to reach $600 mill...es offered by minimally-invasive procedures, inclu...nt comfort and faster patient throughput. ,, ...
(Date:11/30/2009)...ss., Nov. 30 Decision Resources, o...rms focusing on pharmaceutical and healthcare issu...et in Russia will grow nine percent annually over ...n by 2013. This growth will be driven mainly by in...eased use of more-expensive therapies like pegylat...
Breaking Medicine Technology:Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 3Abilities Expo THE Event for People With Disabilities Is FREE and Happening THIS WEEK at the Schaumburg Convention Center 50059 1Abilities Expo THE Event for People With Disabilities Is FREE and Happening THIS WEEK at the Schaumburg Convention Center 50059 2Transave Receives 242 2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE 28TM 29 4650 1Transave Receives 242 2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE 28TM 29 4650 2Transave Receives 242 2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE 28TM 29 4650 3Transave Receives 242 2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE 28TM 29 4650 4Effective pain treatment for cancer patients 3F 50057 1Effective pain treatment for cancer patients 3F 50057 2
...s MRSA-active Bicyclolide, a novel ...ss., Sept. 15 Enanta Pharmaceuticals, a,leader in...drugs, announced,today the initiation of a Phase 1... a first-in-class MRSA-active Bicyclolide, a novel...stance profile. The,clinical development program f...
...American Society Of Clinical Psychopharmacology ...ILLS, Mass., Sept. 15 Joseph F. Finn, Jr.,C.P.A. ... ("Spherics") for,the benefit of creditors, announ... property will be sold at a sealed bid auction on ...ects on cognitive functions at rates of,over 40% i...
Other Medicine Technology:Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA 2Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA 3Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R) 2
(Date:11/30/2009)... 1 Results of a randomized, contro...meeting of the Radiological Society of North Ameri...rrowing or blockage in arteries that supply blood ...significant but silent coronary artery disease. ,... plaque, a combination of fat, cholesterol and oth...
(Date:11/30/2009)...Nov. 30 HealthPlus of Michigan tod...icarePlus plans designed for Medicare-eligible pe...nvenient access to quality health care. ,, Hea...care plans in Michigan, according to the "America,... U.S. News & World Report and the National Com...
(Date:11/30/2009)...dministrator Alonzo L. Fulgham ,, WASHINGTON, ..., the global community once again recognizes World...V/AIDS worldwide. This is also a time to renew ou...s epidemic and pay homage to the millions of peopl...ajor partner in the U.S. President,s Emergency Pla...
(Date:11/30/2009)...v. 30 Major League Baseball,s Ma...ity Royals and recently acquired by the Chicago Wh.... The award is given annually to a Major League Ba...age and dedication of baseball great Fred Hutchins...r-old Redlands, Calif., native made his MLB debut ...
(Date:11/30/2009)...out treatment for blood-borne diseases, researcher...s) -- Many medical students get stuck by needles, ... they often fail to alert hospital authorities, wh... has found. , The researchers interviewed 699 s...hat 415 -- 59 percent -- had experienced needlesti...
Breaking Medicine News(10 mins):Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 3Health News:HealthPlus Launches New Medicare Advantage Plans 2Health News:HealthPlus Launches New Medicare Advantage Plans 3Health News:USAID Recognizes World AIDS Day 2Health News:Mark Teahen Named 2009 Hutch Award Winner 2Health News:Med Students Often Fail to Report Needlestick Injuries 2
...WA and POZ reinvigorate AIDS activism - , , WASHI... with AIDS (NAPWA) and POZ magazine today announ...nver Principles Project. The project aims to enco... HIV/AIDS -- with the ultimate goal of strengtheni...
...effective communication are the root causes , , R...ho live in rural areas are at greater risk of club...al populations, and researchers are beginning to u...ural differences and communication barriers are fa...
...illy USA Business-to-Business Organization and Ove...Bailey,s Leadership Role Expands to Include Lilly ...h 2 Eli Lilly and Company (NYSE: LLY ) today an...U.S. Business-to-Business organization. As vice pr...
...r.com,( http://www.himfr.com/hot-products/ ), on...e than 30 B2B industry websites to its name, recom...Cherry: , Cherry ( http://www.himfr.com/buy-c...ar ( http://www.himfr.com/buy-pear/ ),or orange,...
...rica with NightWave sleep device , , PORTLAND, Or...Week, Coherence Resources, Inc. provided Peace Cor...y need: adequate sleep. Malaria medications taken...olunteers are facing a lot of challenges over ther...
...tio of topical agents for patients with mild to mo...he American Academy of Dermatology (Academy) has r...and treatment of psoriasis with topical therapies ...of six sections of the guidelines of care for psor...
Other Medicine News:Health News:The National Association of People with AIDS (NAPWA) and POZ Magazine Partner to Launch The Denver Principles Project 2Health News:The National Association of People with AIDS (NAPWA) and POZ Magazine Partner to Launch The Denver Principles Project 3Health News:Native American Children are at Greater Risk for Clubfoot Recurrence 2Health News:Native American Children are at Greater Risk for Clubfoot Recurrence 3Health News:Lilly Announces Leadership Changes 2Health News:Lilly Announces Leadership Changes 3Health News:Himfr.com Recommends Five Foods for Spring 2Health News:Sleepless in Botswana 2Health News:Sleepless in Botswana 3Health News:American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies 2Health News:American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies 3Health News:American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies 4Health News:American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies 5Health News:American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies 6
...tive determination of Estradiol (E2) concentration... steroid hormone with a phenolic A ring. This ste...is the most potent natural Estrogen, produced main...by the adrenal cortex, and the male testes. Estrad...
Human Cardiac-Specific Troponin-I Enzyme Immunoassay (cTnI ELISA)
Innotrac Aio! 2nd Generation Troponin I Assay
... a high-throughput immunoassay system built around...000 with the important addition of Logic Driven In... be designed for optimal performance with the fast...critical assays such as the cardiac biomarkers and...
Medicine Products: